Smith & Nephew plc Rating Reiterated by Panmure Gordon (SNN)
Smith & Nephew plc (NYSE:SNN) traded up 0.10% during mid-day trading on Monday, hitting $89.50. The stock had a trading volume of 138,154 shares. Smith & Nephew plc has a one year low of $57.99 and a one year high of $100.90. The stock’s 50-day moving average is $89.2 and its 200-day moving average is $80.81. The company has a market cap of $16.003 billion and a price-to-earnings ratio of 30.78.
Smith & Nephew plc (NYSE:SNN) last posted its quarterly earnings results on Friday, August 1st. The company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.08. Analysts expect that Smith & Nephew plc will post $4.14 EPS for the current fiscal year.
A number of other analysts have also recently weighed in on SNN. Analysts at Numis Securities Ltd reiterated a “hold” rating on shares of Smith & Nephew plc in a research note on Monday. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Smith & Nephew plc in a research note on Monday. Finally, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Smith & Nephew plc in a research note on Monday. Eight analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Smith & Nephew plc has an average rating of “Buy” and a consensus target price of $97.00.
Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (NYSE:SNN) and advanced wound management.
Receive News & Ratings for Smith & Nephew plc (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.